Global Leader In Pharmaceutical Cannabinoid Production Secures $7 Million With Tuatara Capital Leading The Series … – PR Newswire (press release)

Global Leader In Pharmaceutical Cannabinoid Production Secures $7 Million With Tuatara Capital Leading The Series
PR Newswire (press release)
NEW YORK and TAMPA, Fla., March 8, 2016 /PRNewswire/ — CBC Biotechnologies, Inc., (CBCBio), a global leader in the use of synthetic biology to create pharmaceutical grade cannabinoids, announced today it has completed its $7 million Series A fundingĀ …

and moreĀ >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd